Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

MYRIAD GENETICS INC

MYGN Clue Score54
United States Fiscal year ends December CIK 0000899923 Results filed 4 Nov 2026

What the insiders did Net selling

Bought (120 mo)
$1.40M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$80.49M
$3.52M on a plan · $64.15M straight out of an exercise
Sold at will
$12.83M
35 of 122 sales
Net
−$79.10M
−$11.43M against sales at will